These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32256074)

  • 41. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia.
    Weng J; Zhang Y; Li H; Shen Y; Yu W
    Gen Psychiatr; 2019; 32(1):e100026. PubMed ID: 31179423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
    Patel MX; De Zoysa N; Bernadt M; David A
    J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes toward taking medication among outpatients with schizophrenia: cross-national comparison between Tokyo and Beijing.
    Kuroda N; Sun S; Lin CK; Morita N; Kashiwase H; Yang F; Nakatani Y
    Environ Health Prev Med; 2008 Sep; 13(5):288-95. PubMed ID: 19568916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive association between insight and attitudes toward medication in Japanese patients with schizophrenia: Evaluation with the Schedule for Assessment of Insight (SAI) and the Drug Attitude Inventory - 10 Questionnaire (DAI-10).
    Ito S; Matsumoto J; Sakai Y; Miura K; Hasegawa N; Yamamori H; Ishimaru K; Kim Y; Hashimoto R
    Psychiatry Clin Neurosci; 2021 May; 75(5):187-188. PubMed ID: 33715260
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attitude towards second-generation antipsychotics among patients with schizophrenia and their relatives.
    Karthik MS; Kulhara P; Chakrabarti S
    Hum Psychopharmacol; 2013 Sep; 28(5):457-65. PubMed ID: 23784674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.
    Huang Y; Pan L; Teng F; Wang G; Li C; Jin L
    Shanghai Arch Psychiatry; 2017 Oct; 29(5):295-303. PubMed ID: 29276353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insight into illness and attitudes toward medications among inpatients with schizophrenia.
    Sajatovic M; Rosch DS; Sivec HJ; Sultana D; Smith DA; Alamir S; Buckley P; Bingham CR
    Psychiatr Serv; 2002 Oct; 53(10):1319-21. PubMed ID: 12364685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.
    Das AK; Malik A; Haddad PM
    Ther Adv Psychopharmacol; 2014 Oct; 4(5):179-85. PubMed ID: 25360242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
    Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
    J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
    Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients.
    Iasevoli F; Fagiolini A; Formato MV; Prinzivalli E; Giordano S; Balletta R; De Luca V; de Bartolomeis A
    Psychiatry Res; 2017 Mar; 249():159-166. PubMed ID: 28104562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
    Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
    Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient perspectives on antipsychotic treatments and their association with clinical outcomes.
    Liu-Seifert H; Osuntokun OO; Godfrey JL; Feldman PD
    Patient Prefer Adherence; 2010 Oct; 4():369-77. PubMed ID: 21049089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.